ESR1 and breast cancer: On the basis of these facts, the downregulation of ERα expression by TNF-α treatment may contribute to overcoming the resistance to chemotherapy in patients with ERα-positive breast cancer; however, the molecular mechanism underlying this phenomenon remains unclear.